Lifecare AS will hold an Extraordinary General Meeting on May 16th, 2024, at 10:00 (CET).

The notice with complete agenda and documents are available on https://lifecare.no/events/.

It will be possible to attend the meeting in person or digitally through Orgbrain. Shareholders who wish to participate and vote at the Extraordinary General Meeting must be registered with a userprofile in the meeting portal Orgbrain (www.orgbrain.no). 

Further information about participation and registration appears from the notice.

About us
Lifecare AS is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the next generation of Continuous Glucose Monitoring (“CGM”) systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors (“NTR”) on the sensor body for read-out of pressure variations. Lifecare’s sensor technology is referred to as “Sencell” and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts
For further information, please contact:

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs, asle.wingsternes@lifecare.no, +47 41 61 42 52

This information is subject to disclosure under the Norwegian Securities Trading Act, §5-12. The information was submitted for publication at 2024-05-02 20:41 CEST.

Attachments
240502 Notice EGM May 2024
Extraordinary General Meeting

© Modular Finance, source Nordic Press Releases